Government Funding for the Development of Enzalutamide
Authors:
- 1 February 2025
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 11 (2) , 182
Abstract
This cross-sectional study assesses the various patents and US government grants that were critical to the publicly funded development of the cancer drug enzalutamide.Keywords
This publication has 2 references indexed in Scilit:
- California Court of Appeals Decision Affects the Prostate Cancer Drug Market – Medivation Inc. v. Aragon Pharmaceuticals Inc.American Journal of Law & Medicine, 2017
- Increased Survival with Enzalutamide in Prostate Cancer after ChemotherapyNew England Journal of Medicine, 2012